Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. A. Jansson, H. Backman, E. Rönmark, B. Lundbäck, A. Lindberg (Luleå, Umeå, Gothenburg, Sweden). Use of medicines and prevalence of co-morbid diseases in subjects with and without COPD in Sweden. Eur Respir J 2013; 42: Suppl. 57, 3450

Member's Comments

No comment yet.

Related content which might interest you: Comorbidity in patients with IHD - the prevalence of COPD Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Comorbidities, gender-differences and COPD severity: The French Palomb cohort Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Comorbidities and COPD severity: The French Palomb cohort Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Co-morbidities of COPD in primary care Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015 Cardiovascular comorbidities of COPD in never-smokers Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014 Comorbidity in patients with COPD in Russia Source: Annual Congress 2013 –COPD treatment Year: 2013 Prevalence of COPD in vascular diseases Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Comorbidities in patients with COPD and their impact on COPD course Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Comorbidities and burden of COPD: A population based case-control study Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Cardiovascular risk assessment in COPD patients with severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Prevalence of chronic kidney disease (CKD) in the UK COPD population Source: International Congress 2014 – COPD exacerbations Year: 2014 Prevalence and incidence of COPD: The Rotterdam study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Co-morbidity is the main cost driver among COPD-subjects Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014